Akston Biosciences Is A Biotechnology Company Focused On Developing And Manufacturing Protein Therapeutics For Theanimal Health Sectorfounded In 2011 And Based In Beverlymassachusettsakston Aims To Provideinnovativeand Affordablebiotechnological Therapies For Petsbridging Thegap Between Human And Pet Healthcarethecompany Specializes In Creating Novel Therapies Tailored Specifically For Companion Animalsutilizing Its Ambifecta C Fc Fusion Platformakston S Product Pipelineincludes Various Protein Therapies Designed To Address Health Issues In Petsreflecting Its Commitment To Improving Pet Health Outcomeswith A Strong Emphasis On Research And Developmentakston Has Filed 24 Patents Related To Its Innovativeapproaches In Both Animal And Human Health Akston Biosciences Has Raised $ 6 87 Million In Funding And Is Exploring Strategic Options For Growthincluding A Potential Initial Public Offering In 2024Thecompany Is Dedicated To Making Significant Contributions To Theanimal Health Industry Through Its Uniquefocus On Pet Specific Treatments
